Zastosowanie fluorkow w leczeniu osteoporozy

• Autorzy: Chlubek D.
• Języki publikacji: PL

Słowa kluczowe

PL

choroby czlowieka; masa kosci; leczenie; choroby kosci; osteoporoza; fluorki

• Wydawca: -
• Czasopismo: Biuletyn Magnezologiczny
• Rocznik: 1997
• Tom: 02
• Numer: 3
• Opis fizyczny: s.191-197,bibliogr.

Twórcy

autor

Chlubek D.

• Pomorska Akademia Medyczna, 70-952 Szczecin, ul.Rybacka 1

Bibliografia

• Akhter M.P., Turner C.H. (1990): Fluoride intake versus bone strength in rat bones. J. Bone Miner. Res., 5(suppl 1), (98).
• Alhava E.M., Olkkonen H., Kauranen P., Kari T. (1980): The effect of drinking water fluoridation on the fluoride content, strength and mineral density of human bone. Acta Orthop. Scand., 51, (413-420).
• Badurski J., Sawicki A., Boczoń S. (1994): Osteoporoza. Osteoprint, Białystok.
• Baylink D.J., Bernstein D.S. (1967): The effect of fluoride therapy on metabolic bone disease: a histologic study. Clin. Orthop., 55, (51-85).
• Baylink D.J., Farley S.M., Smith L. (1983): Characterisation of skeletal response to fluoride in osteoporosis. Clin. Res., 31, (543A).
• Boivin G. (1978): Morphometry analysis of fluorotic bone tissue. W: Curvoisier B., Donath A., Baud C.A. Symposium CEMO III: Fluoride and bone. Editions Medecine et Hygiee, Geneva.
• Briancon D., Meunier P. (1979): Le traitement de l'osteoporose par l'association fluorure de sodium, calcium, vitamine D. Thesis, Lyon.
• Briancon D, Meunier P.J. (1981): Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop. Clin. North Am., 12, (629-648).
• Buckle R.M. (1989): 3-year study of sodium fluoride treatment on vertebral fracture incidence inosteoporosis. J Bone Miner. Res., 4 (suppl 1), (186).
• Burkhart J.M., Jowsey J. (1968): Effect of variations in calcium intake on the skeleton of fluoride-fed kittens. J. Lab. Clin. Med., 72, (943- 950).
• Cass R.M., Croft J.D., Perkins P., Nye W., Waterhouse C., Terry R. (1966): New bone formation in osteoporosis following treatment with sodium fluoride. Arch. Intern. Med., 118, (111- 116).
• Caverzasio J., Imai T., Amman P., Burgener D, Bonjour J.P. (1996): Aluminium potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. Calcif. Tissue Int., 58, (30-39).
• Chavassieux P., Pastoureau P., Boivin G., Chapuy MC., Delmas P.D., Milhaud G., Meunier P.J. (1991): Fluoride-induced bone changes in lambs during and after exposure to sodium fluoride. Osteoporos. Int., 2, (26-33).
• Cheng P.T., Bader S.M., Grynpas M.D. (1995): Biphasic sodium fluoride effects on bone and bone mineral. A review. Cells and Materials, 5, (271- 282).
• Cremer H.D., Buttner W. (1970): Fluorides in human health. Absorption of fluorides. WHO, Genewa.
• Dambacher M.A., Lauffenburger T., Lammble B., Haas H.G. (1978): Long-term effects of sodium fluoride in osteoporosis. W: Courvoisier B., Donath A. Fluoride and bone. Hans Huber, Geneva.
• Delmas P.D., Dupuis J., Duboeuf F., Chapuy M.C., Meunier P.J. (1990): Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J. Bone Miner Res., 5 (suppl 1), (143-147).
• Duresmith B.A., Farley S.M., Linkhart S.G., Farley JR., Baylink D.J. (1996): Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation J. Clin Endocrinol. Metab., 81, (269-275).
• Ekstrand J., Ehrnebo M., Boreus L.O. (1978): Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin. Pharmacol. Ther., 23, (329-337).
• Eriksen E.F., Mosekilde L., Meisen F. (1985): Effects of sodium fluoride, calcium phosphate and vitamin D2 on bone balance and remodelling in osteoporotics. Bone, 6, (381-390).
• Farley J R., Wergedal J.E., Baylink D.J. (1983): Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science, 222, (330-332).
• Farley S.M., Wergedal J.E., Farley J R., Javier G.N., Schulz EE., Talbot J R., Libanati CR., Lindegren L., Bock M., Goette M.M. (1992): Spinal fractures during fluoride therapy for osteoporosis: relationship to spinal bone density. Osteoporos. Int., 2, (213-218).
• Farley S.M.G., Wergedal J.E., Smith L.C., Lundy M.W., Farley J R., Baylink D.J. (1987): Fluoride therapy for osteoporosis: characteristics of the skeletal response by serial measurement of serum alkaline phosphatase activity. Metabolism, 36, (211-218).
• Fratzl P., Roschger P., Eschberger J., Abendroth B„ Klaushofer K. (1994): Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle X-ray-scattering study. J. Bone Miner. Res., 9, (1541-1549).
• Gambacciani M., Spinetti A., Taponeco F. (1995): Treatment of postmenopausal vertebral osteopenia with monofluorophosphate - a long- term calcium-controlled study. Osteoporos. Int., 5, (467-471).
• Glerum J.L. (1987): Fluoride in osteoporosis. Pharmaceutical and clinical aspects with special attention to a slow release preparation. Thesis, University of Utrecht.
• Gutteridge D.H., Price R.I., Nicholson G.C. (1984): Fluoride in osteoporotic vertebral fractures - trabecular increase, vertebral fractures, femoral fractures. W: Christiansen C. Osteoporosis. Aalborg Stift sbogtrykkeri, Copenhagen.
• Hansson T„ Roos B. (1987): The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3-year) study. Calcif. Tissue Int., 40, (315-317).
• Jowsey J., Riggs B.L., Kelly P.J., Hoffman D.L. (1972): Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am. J. Med., 53, (43-49).
• Jowsey J., Schenk R.K., Reutter F.W. (1968): Some results of the effect of fluoride on bone tissue in osteoporosis. J. Clin. Endocrinol. Metab., 28, (869-874).
• Kanis J.A. (1990): Effect of fluoride on postmenopausal osteoporosis. N. Engl. J. Med., 323, (416-417).
• Kanis J A. (1993): Treatment of symptomatic osteoporosis with fluoride. Am. J. Med., 95 (suppl 5A), (53-61).
• Kanis J.A., Johnell O , Gullberg G, Allander E., Dilsen G., Gennari C., Lpes-Vaz A.A., Lyritis G.P., Mazzuoli G., Miravet L. (1992): Evidence for the efficacy of bone active drugs in the prevention of hip fracture. Br. Med. J , 305, (1124-1128).
• Kanis J.A., Meunier P.J. (1984): Should we use 'fluoride to treat osteoporosis? Q J. Med., 53, (145-164).
• Kleerekoper M., Paterson E.L., Nelson D A, Phillips E., Schork M.A., Tilley B.C., Parfitt AM (1991): A randomized trial of sodium fluoride asa treatment for postmenopausal osteoporosis Osteoporos. Int., 1, (155-161).
• Lee J.R. (1994): Critical review. Fluoride, 27, (227-228).
• Leone N.C., Stevenson C.A., Hilbish T.F, Sosman M.C. (1955): A roentegenologic study of a human population exposed to high-fluoride domestic water: a ten-year study. Am. J Roentgenol. Radium Ther. Nucl. Med., 74, (874- 885).
• Lundy M.W., Stauffer M, Wergedal JE., Baylink D.J., Featherstone J.D., Hodgson S.F, Riggs B.L. (1995): Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos. Int., 5, (115- 129).
• Mamelle N., Meunier P.J., Dusan R , Guillaume M., Martin J.L., Gaucher A., Prost A., Zeigler G, Netter P. (1988): Risk-benefit ratio of sodium fluoride: treatment in primary vertebral osteoporosis. Lancet, 2, (361-365).
• Mamelle N., Meunier P.J., Netter P. (1990): Fluoride and vertebral fractures. (Letter to the editor). Lancet, 336, (243).
• Marcelli C., Meunier P.J. (1994): Fluoride therapy: effect on bone microstructure and biomechanics. Presse Med., 23, (1344-1348).
• Nagant de Deuxchaisnes C., Devogelaer J.P, Depresseux G, Malghem J., Maldague B. (1990): Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J. Bone Miner. Res., 5 (suppl 1), (25-26).
• Newesely H. (1972): Mechanisms and action of trace elements in the mineralization of dental hard tissues. Zyma SA, Nyon.
• Pak C.Y.C., Sakhaee K, Piziak V., Peterson R.D., Breslau N.A., Boud P., Poindexter J.R, Herzog J., Heardsakhaee A., Haynes S, Adamshuet B., Reisch J.S. (1994): Slow-release sodium fluoride in the treatment of postmenopausal osteoporosis. A randomized controlled trial. Ann. Intern. Med., 120, (625-632).
• Parsons V., Mitchell C., Eimond A., Darby A.J. (1983): The use of sodium fluoride and calcium supplements and vitamin D in the treatment of axial osteoporosis. W: Dixon A. St. J., Russell R.G.G., Stamp T.C.B. Osteoporosis - a multidisciplinary problem. Royal Society of Medicine and Academic Press, London.
• Rich C., Ensinck J. (1961): Effect of sodium fluoride on calcium metabolism of human beings. Nature, 213, (191-184).
• Rigalli A., Ballina J.C., Beinlich A.D., Alloatti R., Puche R.C. (1994): Pharmacokinetic differences between sodium fluoride and sodium monofluorophosphate and comparative bone mass increasing activity of both compounds in the rat. Arzneimittelforschung, 44, (762-766).
• Riggs B.L., Hodgson S.F., Hoffman D.L., Kelly P.J., Johnson K.A., Taves D R. (1980): Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 243, (446-449).
• Riggs B.L., Hodgson S.F., O'Fallon W.M., Chao E.Y., Wahner H.W., Muhs J.M., Cedel S.L., Melton L.J. (1990): Effect of fluoride treatment on
• the fixture rate in postmenopausal women with osteoporosis. N. Engl. J. Med., 322, (802-809).
• Roholm K. (1937): Fluorine intoxication: a clinical hygienic study. H.K.Lewis, London.
• Sogaard C.H., Mosekilde L., Richards A. (1994): Marked decrease in trabecular bone quality after five years of sodium fluoride therapy - assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone, 15, (393- 399).
• Teotia S.P.S., Teotia M. (1973): Secondary hyperparathyroidism in patients with endemic skeletal fluorosis. Br. Med. J., 1, (637-640).
• Vose G.P., Keele D.K., Milner A.M., Rawley R., Roach T.L., Sprinkle E.E. (1978): Effect of sodium fluoride, inorganic phosphate and oxymetholone therapies in osteoporosis: a six year progress report. J. Gerontol., 33, (204-212).
• Wolinsky I., Simkin A., Gugqenheim K. (1972): Effects of fluoride on metabolism and mechanical properties of rat bone. Am. J. Physiol., 223, (46- 50).